Wirelessly Powered Electronic Implant, ECHO, Enables Drug-Free Management of ‘Diabesity’
Researchers developed an implantable, wirelessly powered electronic device, ECHO, that uses electrocatalysis to remove excess glucose from the bloodstream on demand, and could offer a drug-free approach to managing obesity and type 2 diabetes (T2D). The post Wirelessly Powered Electronic Implant, ECHO, Enables Drug-Free Management of ‘Diabesity’ appeared first on GEN - Genetic Engineering and…
Scientists at ETH Zurich, the University of Lyon, and the University of Basel have created a wireless, implantable device called ECHO that could manage obesity and type 2 diabetes without drugs. This device, known as electrocatalytic closed-loop health optimization, works by removing excess glucose from the blood when levels are too high.
In tests on mice with both obesity and diabetes, the ECHO device successfully lowered blood glucose to normal levels within an hour and maintained this control for weeks, all without using drugs. The device also helped the mice burn stored fat for energy, leading to weight loss. The researchers, led by Martin Fussenegger, believe this technology could lead to new treatments for metabolic disorders that avoid the side effects and high costs of current drug-based therapies.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
